Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • MICRUS ENDOVASCULAR CORP Financial Overview

  • Income Statement: MEND

      2009 2008 Change ( 2008 - 2009  )
    Net Sales/Revenues 78.20 M 69.21 M 8.98 M 11.49%
    Gross Profit 56.52 M 50.96 M 5.56 M 9.83%
    Net Income Before Extra Items/Preferred Div -11.05 M -16.26 M 5.21 M -47.10%
    Operating Income -9.19 M -18.16 M 8.97 M -97.65%
  • Cash Flow: MEND

      2009 2008 Change ( 2008 - 2009  )
    Net Cash Flow - Financing 4.13 M 3.16 M 963,000.00 23.33%
    Net Cash Flow - Investing 5.01 M 3.44 M 1.57 M 31.36%
    Net Cash Flow/Operating Activities -9.28 M -7.52 M -1.76 M 18.91%
  • Balance Sheet: MEND

      2009 2008 Change ( 2008 - 2009  )
    Total Assets 61.25 M 72.32 M -11.08 M -18.09%
    Total Liabilities 18.67 M 24.14 M -5.47 M -29.30%
    Shareholders Equity 42.57 M 48.18 M -5.61 M -13.17%
  • Key Ratios / Statistics: MEND

    • Valuation

      Price/Earnings (TTM) -10.18
      Price/Sales (TTM) 2.59
      Price/Book (MRQ) 3.01
      Price/Cash Flow (TTM) 33.89
    • Profitability

      Gross Margin 72.28
      Operating Margin -11.75
      Profit Margin -14.14
    • Dividends

      Dividend Paid (TTM) 0.00
      Payout Ratio % (TTM) 0.00
    • Financial Strength

      Quick Ratio (MRQ) 1.62
      Current Ratio (MRQ) 2.79
      Long Term Debt-to-Equity (MRQ) 0.00
    • Management Effectiveness

      Return on Equity (TTM) -21.02
      Return on Assets (TTM) -3.38
      Return on Investments (TTM) -23.63